Promoting innovation and excellence to face the rapid diffusion of novel Psychoactive substances in the EU: The outcomes of the reDNet project

Human Psychopharmacology

Volumn 28, Issue 4, 2013, Pages 317-323

  Corazza, Ornella ^a,b   Assi, Sulaf ^a   Simonato, Pierluigi ^a   Corkery, John ^a   Bersani, Francesco Saverio ^a   Demetrovics, Zsolt ⁱ   Stair, Jacqueline ^a   Fergus, Suzanne ^a   Pezzolesi, Cinzia ^a   Pasinetti, Manuela ^a   Deluca, Paolo ^b   Drummond, Colin ^b   Davey, Zoe ^b   Blaszko, Ursula ^b   Moskalewicz, Jacek ^j   Mervo, Barbara ⁱ   Furia, Lucia Di ^h   Farre, Maggi ^f   Flesland, Liv ^d   Pisarska, Agnieszka ^j   Shapiro, Harry ^c   Siemann, Holger ^e   Skutle, Arvid ^d   Sferrazza, Elias ^a   Torrens, Marta ^f   Sambola, F ^f   Van Der Kreeft, Peer ^g   Scherbaum, Norbert ^e   Schifano, Fabrizio ^a   more..

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c DrugScope   (United Kingdom)

^d Bergen Clinics Foundation   (Norway)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f HOSPITAL DEL MAR   (Spain)

^g De Sleutel   (Belgium)

^h Servizio Salute Regione Marche   (Italy)

ⁱ National Institute for Drug Prevention   (Hungary)

^j INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

more..

Author keywords

addiction; new psychoactive compounds; public health

Indexed keywords

4' METHYLMETHCATHINONE; 5 METHOXYTRYPTAMINE; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CATHINONE; CENTRAL STIMULANT AGENT; ERYTHROMYCIN; ETICYCLIDINE; GAMMA BUTYROLACTONE; PHENCYCLIDINE; PHENETHYLAMINE; PHENETHYLAMINE DERIVATIVE; PIPERAZINE; PREGABALIN; PSYCHOTROPIC AGENT; SYNTHETIC CANNABIMIMETIC; TRYPTAMINE; UNCLASSIFIED DRUG;

ADULT; BELGIUM; CONFERENCE PAPER; DRUG CONTROL; E-MAIL; EDUCATION PROGRAM; EUROPEAN UNION; GERMANY; HEALTH PRACTITIONER; HUMAN; HUNGARY; INFORMATION DISSEMINATION; INFORMATION SERVICE; INFORMATION SYSTEM; INTERNATIONAL COOPERATION; INTERNET; ITALY; LANGUAGE; LEARNING ENVIRONMENT; MASS COMMUNICATION; MOBILE PHONE; MULTIMEDIA; NORWAY; POLAND; POLICY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SALVIA DIVINORUM; SEARCH ENGINE; SOCIAL NETWORK; SPAIN; UNITED KINGDOM; VIRTUAL REALITY;

ADDICTION; NEW PSYCHOACTIVE COMPOUNDS; PUBLIC HEALTH;

DATABASES, FACTUAL; EUROPEAN UNION; HUMANS; INFORMATION SERVICES; INTERNATIONAL COOPERATION; INTERNATIONALITY; INTERNET; MULTILINGUALISM; PSYCHOTROPIC DRUGS; STREET DRUGS; TIME FACTORS;

EID: 84880815938     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2299     Document Type: Conference Paper

References (21)

1. Alberani V, De Castro P, Rossi Mazza AM,. 1990. The use of grey literature in health sciences: a preliminary survey. Bull Med Libr Assoc 78 (4): 358-363.
2. Assi S, Fergus JL, Stair J, Corazza O, Schifano F,. 2011a. Emergence and identification of new products of designer drug products from the Internet. European Pharmaceutical Review. 16 (4): 68-72.
3. Assi S, Watt R, Moffat T,. 2011b. Comparison of laboratory and handheld raman instruments for the identification of counterfeit medicines. Spectroscopy, June, 40-50.
4. Assi S, Watt R, Moffat A,. 2011c. On the quantification of ciprofloxacin in proprietary Ciproxin tablets and generic ciprofloxacin tablets using handheld Raman spectroscopy. J Raman Spectros. doi: 10.1002/jrs.3125.
5. Assi S, Watt R, Moffat A,. 2011d. Identification of counterfeit medicines from the Internet and the world market using near-infrared spectroscopy. Anal Meth 3: 2231-2236.
6. Assi S, Fergus S, Stair JL,. 2012. Identification of novel psychoactive substances (NPS) using hyphenated mass spectrometric techniques. Spectroscopy, 2012, 1 March. Special issue.
7. CASA: The National Centre on Addiction and Substance Abuse at Columbia University. 2008. You've Got Drugs! V: Prescription Drugs Pushers on the Internet, CASA fifth annual report.
8. Corazza O, Assi S, Corkery J, et al,. 2011a. Novel drugs, novel solutions: exploring the potential of technological tools for prevention of drug abuse. Italian Journal of Addictions 1: 25-30.
9. Corazza O, Schifano F, Farre M, et al,. 2011b. Designer drugs on the Internet: a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly. Curr Clin Pharmacol May 1; 6 (2): 125-129.
10. Corazza O, Schifano F, Simonato P, et al,. 2011c. The phenomenon of new drugs on the Internet: a study on the diffusion of the ketamine derivative methoxetamine ('MXE'). Hum Psychopharmacol Clin Exp 27: 145-149.
11. Corazza O, Demetrovics Z, van den Brink W, Schifano F,. 2013. 'Legal highs' an inappropriate term for 'novel psychoactive drugs' in drug prevention and scientific debate. Int J Drug Policy 24: 82-83.
12. Davies S, Terry L, Ramsey J, Dargan PI, Wood DM,. 2012. Risk of caffeine toxicity associated with the use of 'legal highs' (novel psychoactive substances). Eur J Clin Pharmacol 68 (4): 435-439.
13. Deluca P, Davey Z, Corazza O, et al,. 2012. Indentifying emerging trends in recreational drug use; outcomes from the Paychonaut Web Mapping project. Prog Neuropharmacol Biol Psychiatry 3:39 (2): 221-226.
14. EMCDDA-Europol. 2010. Annual Report on the implementation of Council Decision 2005/387/JHA, Lisbon.
15. Foreman RF, Marlow DB, McLellan AT,. 2006. The Internet a source of drugs of abuse. Curr Psych Rep. 8: 377-382.
16. Littlejohn C, Baldacchino A, Schifano F, Deluca P,. 2005. Internet pharmacies and online prescription drug sales: a cross-sectional study. Drugs Educ Prev and Policy 12: 75-80.
17. Schifano F, Leoni M, Martinotti G, Rawaf S, Rovetto F,. 2003. Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project. Cyberpsychol Behav 6 (4): 405-410.
18. Schifano F, Deluca P, Agosti L, et al,. 2005. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). J Psychopharmacol 19 (6): 675-679.
19. Schifano F, Deluca, P, Baldacchino A, et al,. 2006. Drugs on the web; the Psychonaut 2002 EU project. Prog Neuropsychopharmacol Biol Psychiatry 30 (4): 640-646.
20. Sigismondi I, Corazza O,. 2012. The emergence of novel psychoactive substances (NPS) and a new challenge for EU legislation. In Book of Abstracts. The First International Conference on Nov elPsychoactive Substances. The Ever-Changing Worls of Psychoactive Drugs, Addictologia Hungarica, 11. Supplementum 1, Corazza O, Demetrovics Z, Mervó B, Brady K,. (eds.). L'Harmattan Könyvkiadó: Budapest; 22-23.
21. Vanattou-Saifoudine N, McNamara R, Harkin A,. 2010. Mechanism and mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats. Br J Pharmacol 160 (4): 860-877.